Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line

Young J. Oh, Shou C. Wong, Mark Moffat, Karen L. O’Malley

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)


In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP+ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.

Original languageEnglish
Pages (from-to)157-167
Number of pages11
JournalNeurobiology of Disease
Issue number3
Publication statusPublished - 1995

Bibliographical note

Funding Information:
We thank Drs Stanley J. Korsmeyer, Dennis W. Choi, Richard Todd and J. Koh for thoughtful discussions and critical reading of parts of this manuscript, Dr E. M. Johnson for many valuable discussions and suggestions, and for the use of equipment, and T. L. Deckwerth for his technical assistance. We also gratefully acknowledge Drs A. Heller, L.Wong and D. Hoffman not only for providing us with the MN9D cell line but also for their many insightful comments in using this system. A portion of this work is published in abstract form. Supported by NIA 44626, MH45530 and NS54982.

All Science Journal Classification (ASJC) codes

  • Neurology


Dive into the research topics of 'Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line'. Together they form a unique fingerprint.

Cite this